更正：放射治疗、威尔姆斯瘤1（WT1）树突状细胞疫苗疗法和α-半乳糖神经酰胺脉冲树突状细胞疫苗疗法联合用于晚期小肠癌
Correction: Combination of Radiation Therapy, Wilms' Tumor 1 (WT1) Dendritic Cell Vaccine Therapy, and α-Galactosylceramide-Pulsed Dendritic Cell Vaccine Therapy for End-Stage Small Bowel Cancer.
作者信息
Nagai Hisashi, Chen Hao, Karube Ryusuke, Koitabashi Yusuke, Numata Ouka, Yamahara Kenichi
机构信息
Department of Human Development - Environment and Resources, Graduate School of Human and Environmental Studies, Tokai University, Kanagawa, JPN.
Department of Regenerative Medicine, Ginza Phoenix Clinic, Tokyo, JPN.
出版信息
Cureus. 2025 May 5;17(5):c220. doi: 10.7759/cureus.c220. eCollection 2025 May.
Abstract
[This corrects the article DOI: 10.7759/cureus.64972.].
摘要
[本文更正了文章的数字对象标识符：10.7759/cureus.64972。]
相似文献
1
Correction: Combination of Radiation Therapy, Wilms' Tumor 1 (WT1) Dendritic Cell Vaccine Therapy, and α-Galactosylceramide-Pulsed Dendritic Cell Vaccine Therapy for End-Stage Small Bowel Cancer.更正：放射治疗、威尔姆斯瘤1（WT1）树突状细胞疫苗疗法和α-半乳糖神经酰胺脉冲树突状细胞疫苗疗法联合用于晚期小肠癌
Cureus. 2025 May 5;17(5):c220. doi: 10.7759/cureus.c220. eCollection 2025 May.
2
Combination of Radiation Therapy, Wim's Tumor 1 (WT1) Dendritic Cell Vaccine Therapy, and α-Galactosylceramide-Pulsed Dendritic Cell Vaccine Therapy for End-Stage Small Bowel Cancer.放射治疗、Wim肿瘤1（WT1）树突状细胞疫苗疗法和α-半乳糖神经酰胺脉冲树突状细胞疫苗疗法联合治疗晚期小肠癌
Cureus. 2024 Jul 20;16(7):e64972. doi: 10.7759/cureus.64972. eCollection 2024 Jul.
3
Dendritic cell-based immunotherapy targeting Wilms' tumor 1 in patients with recurrent malignant glioma.针对复发性恶性胶质瘤患者中威尔姆斯瘤1的基于树突状细胞的免疫疗法。
J Neurosurg. 2015 Oct;123(4):989-97. doi: 10.3171/2015.1.JNS141554. Epub 2015 Aug 7.
4
Dendritic cell vaccination in combination with erlotinib in a patient with inoperable lung adenocarcinoma: a case report.树突状细胞疫苗联合厄洛替尼治疗无法手术的肺腺癌 1 例报告。
J Med Case Rep. 2024 Feb 10;18(1):88. doi: 10.1186/s13256-024-04363-z.
5
Dendritic cells pulsed with multifunctional Wilms' tumor 1 (WT1) peptides combined with multiagent chemotherapy modulate the tumor microenvironment and enable conversion surgery in pancreatic cancer.树突状细胞负载多功能 Wilms' 肿瘤 1（WT1）肽与联合化疗药物调节胰腺癌肿瘤微环境并促进转化手术。
J Immunother Cancer. 2024 Oct 8;12(10):e009765. doi: 10.1136/jitc-2024-009765.
6
Dendritic Cells Pre-Pulsed with Wilms' Tumor 1 in Optimized Culture for Cancer Vaccination.在优化培养条件下用肾母细胞瘤1预脉冲的树突状细胞用于癌症疫苗接种
Pharmaceutics. 2020 Mar 28;12(4):305. doi: 10.3390/pharmaceutics12040305.
7
Wilms' tumor 1 -targeting cancer vaccine: Recent advancements and future perspectives.Wilms 瘤 1 靶向癌症疫苗：最新进展与未来展望。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2296735. doi: 10.1080/21645515.2023.2296735. Epub 2023 Dec 26.
8
Delayed-Type Hypersensitivity: An Excellent Indicator of Anti-tumor Immunity With Wilms' Tumor 1 (WT1) Dendritic Cell Vaccine Therapy.迟发型超敏反应：威尔姆斯瘤1（WT1）树突状细胞疫苗治疗抗肿瘤免疫的良好指标
Cureus. 2023 Nov 22;15(11):e49221. doi: 10.7759/cureus.49221. eCollection 2023 Nov.
9
Chemoimmunotherapy targeting Wilms' tumor 1 (WT1)-specific cytotoxic T lymphocyte and helper T cell responses for patients with pancreatic cancer.针对胰腺癌患者的 Wilms' 肿瘤 1（WT1）特异性细胞毒性 T 淋巴细胞和辅助性 T 细胞反应的化学免疫疗法。
Oncoimmunology. 2014 Dec 15;3(10):e958950. doi: 10.4161/21624011.2014.958950. eCollection 2014 Nov.
10
Impact of mature dendritic cells pulsed with a novel WT1 helper peptide on the induction of HLA‑A2‑restricted WT1‑reactive CD8+ T cells.新型 WT1 辅助肽致敏的成熟树突状细胞对诱导 HLA-A2 限制性 WT1 反应性 CD8+ T 细胞的影响。
Int J Oncol. 2020 Oct;57(4):1047-1056. doi: 10.3892/ijo.2020.5110. Epub 2020 Aug 14.
Zotero 插件